Fig. 4: nferX single-cell platform analysis of NR3C1 expression. | Cell Death Discovery

Fig. 4: nferX single-cell platform analysis of NR3C1 expression.

From: Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients

Fig. 4

In a study of peripheral blood samples from healthy donors (n = 6) and COVID-19 patients between days 2 and 16 of symptom onset (n = 7), NR3C1 was appreciably expressed in diverse immune cell types including T cells, B cells, dendritic cells, monocytes, and plasmacytoid dendritic cells.

Back to article page